Queensland Health have advised that the following documents on the COVID-19 Clinical Guidelines page have been updated:
The Decision Pathway for treatment of mild-moderate COVID-19 in Adults
The Guideline on the use of COVID-19 therapeutics for the treatment of SARS-CoV-2 in Adults
The changes include:
Updates to the place in therapy for molnupiravir (second line) following revised NCET guidance.
Updated information for tixagevimab-cilgavimab (Evusheld) regarding efficacy against circulating strains as per NCET, and LAM processes relating to expected expiry of National Medical Stockpile (NMS) stock on December 31st.
Share on:
Welcome to the Gold Coast Primary Health Network
So we can provide you with the most accurate information,
please tell us a little more about yourself